Agilent Technologies, Inc. (LON:0HAV)
Market Cap | 29.80B |
Revenue (ttm) | 5.13B |
Net Income (ttm) | 922.58M |
Shares Out | n/a |
EPS (ttm) | 3.24 |
PE Ratio | 32.30 |
Forward PE | 23.93 |
Dividend | 0.76 (0.53%) |
Ex-Dividend Date | Sep 30, 2025 |
Volume | 717 |
Average Volume | 910 |
Open | 139.49 |
Previous Close | 138.69 |
Day's Range | 138.81 - 142.85 |
52-Week Range | 96.93 - 153.50 |
Beta | 1.24 |
RSI | 73.78 |
Earnings Date | Nov 20, 2025 |
About Agilent Technologies
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry inst... [Read more]
Financial Performance
In 2024, Agilent Technologies's revenue was $6.51 billion, a decrease of -4.73% compared to the previous year's $6.83 billion. Earnings were $1.29 billion, an increase of 3.95%.
Financial numbers in USD Financial StatementsNews

Agilent Technologies, Inc. (A) gilent Technologies, Inc. Presents at Bank of merica Global Healthcare Conference 2025 Transcript
Agilent Technologies, Inc. (NYSE:A) gilent Technologies, Inc. Bank of merica Global Healthcare Conference 2025 September 25, 2025 4:50 AM EDT Company Participants Padraig McDonnell - CEO, President &...

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities SEOUL, South Korea , Sept. 22, 2025 /PRN...
Daily Dividend Report: MMC,A,CUZ,CVS,CPB
The Board of Directors of Marsh McLennan today declared a quarterly dividend of $0.90 per share on outstanding common stock, payable on November 14, 2025, to stockholders of record on October 2, 2025....
Agilent Technologies declares $0.248 dividend

Agilent Announces Cash Dividend of 24.8 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on Oct. 22,...
Agilent Technologies (A) Receives Price Target Increase by Wells Fargo | A Stock News
Agilent Technologies (A) Receives Price Target Increase by Wells Fargo | A Stock News

Agilent to Participate in 2025 Bank of America Global Healthcare Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that President and CEO Padraig McDonnell will participate in a fireside chat at this year's Bank of America Gl...
Agilent Technologies Achieves Top-Level Green Lab Certification | A stock news
Agilent Technologies Achieves Top-Level Green Lab Certification | A stock news

Agilent Refurbishment Centers Achieve Top-Level My Green Lab Certification
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its Refurbishment Centers in Delaware, USA, and Singapore have achieved the highest level of My Green Lab...
Agilent (A) CEO on PFAS Testing Growth & Creating Advanced Instruments for Science
Padraig McDonnell, CEO of Agilent (A), joins to discuss the company's latest earnings. Agilent creates analytical instruments and software for life science markets: “we enable breakthroughs” in areas ...
Insider Sell: Padraig Mcdonnell Sells Shares of Agilent Technologies Inc (A)
Insider Sell: Padraig Mcdonnell Sells Shares of Agilent Technologies Inc (A)
Agilent Technologies, Inc. (A) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Agilent Technologies Announces European Launch at ECP 2025 | A stock news
Agilent Technologies Announces European Launch at ECP 2025 | A stock news

Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its participation as a premium sponsor at the upcoming European Congress of Pathology (ECP) 2025, taking place...

Agilent's MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification unde...
Agilent Technologies Inc (A)'s Winning Formula: Financial Metrics and Competitive Strengths
Agilent Technologies Inc (A)'s Winning Formula: Financial Metrics and Competitive Strengths
Decoding Agilent Technologies Inc (A): A Strategic SWOT Insight
Decoding Agilent Technologies Inc (A): A Strategic SWOT Insight

Earnings Summary: Agilent (A) reports higher Q3 2025 revenue and profit
Healthcare company Agilent Technologies Inc. (NYSE: A) has reported higher revenue and adjusted earnings for the third quarter of fiscal 2025. The company also issued guidance. Agilent’s Q3 revenue ro...
Agilent: Growth Across All Segments, But Investors Will Need To Be Patient
Agilent raises 2025 revenue outlook to $6.91B–$6.93B as core growth accelerates to 6.1% in Q3
Agilent Technologies, Inc. (A) Q3 2025 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A) Q3 2025 Earnings Conference Call August 27, 2025 4:30 PM ETCompany ParticipantsAngelica A.
Agilent Technologies, Inc. 2025 Q3 - Results - Earnings Call Presentation

Agilent Reports 10% Revenue Jump in Q3

Agilent Raises Outlook on Q3 Growth

Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.74 billion for the third quarter ended July 31, 2025, exceeding revenue guidance and representing...